Development and in vitro evaluation of Eudragit E100 and PVP based matrix films for the transdermal delivery of Repaglinid

The study aims the feasibility of transdermal delivery of an antidiabetic agent Repaglinide for controlled and extended release by formulating as matrix film using Eudragit E100 and polyvinylpyrrolidone (PVP). The films were prepared by solvent evaporation technique and characterized in vitro for ph...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The pharma innovation 2015-02, Vol.3 (12, Part A), p.16
Hauptverfasser:	Vijaya, R, Uma Maheshwari S, Jaya, Bharathi S
Format:	Artikel
Sprache:	eng
Schlagworte:	Cellulose acetate Transdermal medication
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!